Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;5(2):75-85.
doi: 10.1007/s40610-019-0118-1. Epub 2019 Feb 9.

Molecular Control of Phosphorus Homeostasis and Precision Treatment of Hypophosphatemic Disorders

Thomas J Weber  1 , L Darryl Quarles  2
Affiliations

Molecular Control of Phosphorus Homeostasis and Precision Treatment of Hypophosphatemic Disorders

Thomas J Weber et al. Curr Mol Biol Rep. 2019 Jun.

Abstract

Purpose of review: Serum phosphorus is maintained in a narrow range by balancing dietary phosphate absorption, influx and efflux of phosphorus from bone and intracellular stores, and renal reabsorption of filtered phosphate. Acute hypophosphatemia, typically caused by transient increases in cellular uptake, can lead to severe complications such as cardiopulmonary dysfunction and rhabdomyolysis that can warrant parenteral phosphate repletion. Chronic hypophosphatemia, however, generally represents true phosphate deficiency and may result in long-term metabolic and skeletal complications, particularly in children due to the critical importance of phosphorus to skeletal mineralization and longitudinal growth.

Recent findings: In addition to the well characterized roles of vitamin D and parathyroid hormone (PTH), a new bone-kidney axis has been discovered that regulates phosphate homeostasis through the bone-derived hormone Fibroblast Growth Factor 23 (FGF23) and its phosphaturic actions that are mediated by activation of fibroblast growth factor receptors (FGFRs) complexed with α-Klotho in renal tubules. Chronic hypophosphatemia can now be classified as FGF23 dependent or independent.

Summary: In cases of FGF23 dependent hypophosphatemia, traditional non-specific treatments with elemental phosphorus and 1,25(OH)2 vitamin D (calcitriol) can now be replaced with a targeted approach by using an FGF-23 blocking antibody (Burosumab).

Keywords: Hypophosphatemia; fibroblast growth factor 23; mineral metabolism; osteomalacia; parathyroid hormone; rickets; vitamin D.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Regulation of systemic phosphate homeostasis.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bergwitz C, Juppner H: Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 2010, 61:91–104. - PMC - PubMed
    1. Berndt T, Kumar R: Novel mechanisms in the regulation of phosphorus homeostasis. Physiology (Bethesda) 2009, 24:17–25. - PMC - PubMed
    1. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998, 31:607–617. - PubMed
    1. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997, 386:78–81. - PubMed
    1. Camalier CE, Yi M, Yu LR, Hood BL, Conrads KA, Lee YJ, Lin Y, Garneys LM, Bouloux GF, Young MR, et al.: An integrated understanding of the physiological response to elevated extracellular phosphate. J Cell Physiol 2013, 228:1536–1550. - PMC - PubMed

LinkOut - more resources